Standout Papers

CXCL11-armed oncolytic adenoviruses enhance CAR-T cell therapeutic efficacy and reprogram tumor microenvironment in gliob... 2022 2026 2023 2024125
  1. CXCL11-armed oncolytic adenoviruses enhance CAR-T cell therapeutic efficacy and reprogram tumor microenvironment in glioblastoma (2022)
    Guoqing Wang, Zongliang Zhang et al. Molecular Therapy

Immediate Impact

61 standout
Sub-graph 1 of 22

Citing Papers

From ex vivo to in vivo chimeric antigen T cells manufacturing: new horizons for CAR T-cell based therapy
2025 Standout
Glioblastoma: Clinical Presentation, Multidisciplinary Management, and Long-Term Outcomes
2025 Standout
1 intermediate paper

Works of Hexian Li being referenced

CXCL11-armed oncolytic adenoviruses enhance CAR-T cell therapeutic efficacy and reprogram tumor microenvironment in glioblastoma
2022 Standout

Author Peers

Author Last Decade Papers Cites
Hexian Li 206 112 111 22 421
Yanting Duan 178 125 151 29 393
Robert W. Sharpe 90 83 53 21 445
Anja Germann 114 119 261 20 474
Tuan Truong 92 244 74 27 494
Firas Hamdan 203 164 155 20 421
Sandrine Vessillier 160 115 191 29 450
Jason E. Ekert 139 88 146 12 493
Judit Fazekas 148 145 116 20 424
Kamel Chettab 139 80 173 29 463
Paul Castillo 319 145 125 33 437

All Works

Loading papers...

Rankless by CCL
2026